238-239DOI: 10.17235/reed.2021.8482/2021
Original
Psychological disorders and coping strategies in patients with inflammatory bowel disease. Their impact on health-related quality of life
DOI: 10.17235/reed.2023.9935/2023
Digestive Diseases Image
Enteroenteric intussusception caused by a small bowel metastatic cutaneous melanoma
DOI: 10.17235/reed.2023.9876/2023
Sarcopenia and treatment failure in inflammatory bowel disease: a systematic review and meta-analysis
DOI: 10.17235/reed.2023.9808/2023
Letter
Small bowel cavernous hemangioma as an uncommon cause of iron-deficiency anemia
DOI: 10.17235/reed.2023.9778/2023
1-L polyethylene glycol + ascorbic acid versus sodium picosulfate + magnesium citrate bowel preparations for colonoscopy: effectiveness and safety
DOI: 10.17235/reed.2023.9785/2023
Unusual presentation of jejunal adenocarcinoma and ovarian metastasis
DOI: 10.17235/reed.2023.9658/2023
Intestinal obstruction due to pneumatosis intestinalis
DOI: 10.17235/reed.2023.9608/2023
Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis
DOI: 10.17235/reed.2023.9537/2023
Fecal immunochemical test for hemoglobin versus fecal calprotectin to monitor endoscopic activity in inflammatory bowel disease
DOI: 10.17235/reed.2023.9536/2023
The HLA-DQA1*05 genotype does not influence the clinical response to ustekinumab and vedolizumab
DOI: 10.17235/reed.2023.9491/2023
Hepatosplenic T-cell lymphoma and inflammatory bowel disease
DOI: 10.17235/reed.2023.9472/2023
Editorial
Relevance of patient-reported outcome measures (PROM) and patient-reported experience measures (PREM) to assess disease status and quality of care in patients with inflammatory bowel disease
DOI: 10.17235/reed.2023.9563/2022
Reply: SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents
DOI: 10.17235/reed.2023.9438/2022
Isolated Jejunal Crohn's Disease: a challenging diagnosis
DOI: 10.17235/reed.2022.9423/2022
Henoch-Schönlein purpura masquerading as Crohn’s disease flare
DOI: 10.17235/reed.2022.9414/2022
Duodenal diastatic perforation due to double gastric and jejunal trichobezoar in a patient with Rapunzel syndrome
DOI: 10.17235/reed.2023.9394/2022
SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents: correspondence
DOI: 10.17235/reed.2023.9347/2022
Prediagnosis of soft tissue infection that was finally diagnosed as pyoderma gangrenosum of ulcerative colitis
DOI: 10.17235/reed.2022.9332/2022
Burkitt’s lymphoma in the adult as an unusual cause of large bowel obstruction
DOI: 10.17235/reed.2022.9306/2022
Impact of SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents: a systematic review and meta-analysis
DOI: 10.17235/reed.2022.9264/2022
A “push-and-pull” trick for endoscopic removal of buckyballs impacted in the esophagus and gastric fundus
DOI: 10.17235/reed.2022.9222/2022
Use of teduglutide for short bowel syndrome and Crohn’s disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy
DOI: 10.17235/reed.2022.9194/2022
Crohn’s disease induced by ocrelizumab in a patient with multiple sclerosis
DOI: 10.17235/reed.2022.9152/2022
Efficacy-safety profile of the video capsule endoscopy in the study of the small bowel: experience over 100 consecutive procedures
DOI: 10.17235/reed.2022.9102/2022
Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study
DOI: 10.17235/reed.2022.9101/2022
Review
“Out of the box” new therapeutic strategies for Crohn´s disease: moving beyond biologics
DOI: 10.17235/reed.2022.9010/2022
The neutrophil-lymphocyte ratio as a predictor of steroid response in patients with severe ulcerative colitis: a retrospective cohort study
DOI: 10.17235/reed.2022.9006/2022
Primary small bowel follicular lymphoma: the role of balloon-assisted enteroscopy in diagnosis and follow-up
DOI: 10.17235/reed.2022.8943/2022
Nutritional benefits in pediatric patients with percutaneous endoscopic gastrostomy placement
DOI: 10.17235/reed.2022.8866/2022
Is urgent colonoscopy without bowel preparation really useful? Colonoscopy without bowel preparation
DOI: 10.17235/reed.2022.8850/2022
Encephalopathy in short bowel syndrome: a diagnostic challenge
DOI: 10.17235/reed.2022.8826/2022
Efficacy and safety of fecal microbiota transplant for recurrent Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis
DOI: 10.17235/reed.2022.8814/2022
One appendix too many: a severe IBD-U case in remission after appendectomy
DOI: 10.17235/reed.2022.8809/2022
Impact of proactive therapeutic drug monitoring of infliximab during the induction phase in IBD patients. A Bayesian approach
DOI: 10.17235/reed.2022.8781/2022
Combined aortic mural thrombi and limb ischemia in inflammatory bowel disease – A rare vascular manifestation
DOI: 10.17235/reed.2022.8774/2022
Practical approach to irritable bowel syndrome-diarrhea beyond low-FODMAP diet
DOI: 10.17235/reed.2022.8749/2022
Endoscopic and ultrasound image of an ileocolic intussusception. An unusual finding in adult patients
DOI: 10.17235/reed.2022.8729/2022
Primary intestinal lymphangiectasia: a rare disease as a cause of protein-losing enteropathy
DOI: 10.17235/reed.2022.8673/2022
Health-related quality of life decline in clinically stable inflammatory bowel disease patients during the COVID-19 outbreak
DOI: 10.17235/reed.2022.8668/2022
Large bowel obstruction secondary to a simple renal cyst: an exceptional complication
DOI: 10.17235/reed.2022.8623/2022
Multiple bezoars causing small bowel obstruction: a unique case of resolution with upper and low GI endoscopy
DOI: 10.17235/reed.2021.8459/2021
Small bowel angioedema. An unusual condition with an interesting differential diagnosis
DOI: 10.17235/reed.2021.8407/2021
Inflammatory bowel disease new-onset during secukinumab therapy: real-world data from a tertiary center
DOI: 10.17235/reed.2021.8397/2021
Wernicke encephalopathy following advanced caecum cancer
DOI: 10.17235/reed.2021.8343/2021
Anal neoplasia and perianal Crohn’s disease: myth or reality?
DOI: 10.17235/reed.2021.8317/2021
Apoptotic colopathy as a manifestation of Good’s syndrome
DOI: 10.17235/reed.2021.8297/2021
Radon exposure and inflammatory bowel disease in a radon prone area
DOI: 10.17235/reed.2021.8239/2021
Comparison of satisfaction degree of patients treated at the Inflammatory Bowel Disease Unit (IBDU) of Hospital Universitario 12 de Octubre between previous face-to-face care and telephone care during the COVID-19 pandemic
DOI: 10.17235/reed.2021.8185/2021
Duodenal-type follicular lymphoma: a silent tumor
DOI: 10.17235/reed.2021.8149/2021
Endometriosis-associated intestinal tumors: a new challenge in clinical practice
DOI: 10.17235/reed.2021.8140/2021
Evaluation of a new composite score combining SPICE and protrusion angle scores to distinguish submucosal lesions from innocent bulges
DOI: 10.17235/reed.2021.8080/2021
Pneumatosis intestinalis in anorexia nervosa
DOI: 10.17235/reed.2021.8013/2021
Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of the Epi-IBD 2011 study in the Vigo area
DOI: 10.17235/reed.2021.8003/2021
Timing of enteroscopy in overt-obscure gastrointestinal bleeding: a systematic review and meta-analysis
DOI: 10.17235/reed.2021.7976/2021
ABP 501 (adalimumab-atto) in the treatment of inflammatory bowel disease: an example of evidence-based extrapolation
DOI: 10.17235/reed.2021.7921/2021
Impact of Epstein-Barr virus infection on inflammatory bowel disease (IBD) clinical outcomes
DOI: 10.17235/reed.2021.7915/2021
Pneumoperitoneum and COVID-19. A causal association?
DOI: 10.17235/reed.2021.7877/2021
Pneumatosis intestinalis as an incidental finding in a patient with COVID-19 infection
DOI: 10.17235/reed.2021.7857/2021
The COVID-19 pandemic shows us in which way the care of patients with inflammatory bowel disease should move
DOI: 10.17235/reed.2021.7765/2020
Endoscopic forceps removal for complicated magnetic beads impaction
DOI: 10.17235/reed.2021.7731/2020
Irritable bowel syndrome and basal serum tryptase: correlation between subtype, severity, and comorbidities. A pilot study
DOI: 10.17235/reed.2021.7697/2020
The diagnostic value of capsule endoscopy in children with intestinal lymphangiectasia
DOI: 10.17235/reed.2021.7682/2020
Use of the Boston Bowel Preparation Scale in the real life setting: what affects it?
DOI: 10.17235/reed.2020.7678/2020
Spontaneous intramural small-bowel hematoma: a cause of acute abdomen in anticoagulated patients
DOI: 10.17235/reed.2021.7640/2020
Biosimilar infliximab CPT-13 for inflammatory bowel disease in a real clinical setting: pharmacokinetic outcomes, immunogenicity, and drug survival
DOI: 10.17235/reed.2021.7638/2020
Spontaneous pneumoperitoneum and pneumatosis intestinalis as sole manifestations of a COVID-19 infection. An extremely rare complication
DOI: 10.17235/reed.2020.7601/2020
Management of small intestinal bacterial overgrowth by pediatric gastroenterologists in Spain
DOI: 10.17235/reed.2020.7582/2020
Adherence to intravenous biological treatment in inflammatory bowel disease patients during the COVID-19 pandemic
DOI: 10.17235/reed.2020.7562/2020
Consequences and management of COVID-19 on the care activity of an Inflammatory Bowel Disease Unit
DOI: 10.17235/reed.2020.7543/2020
A case of severe diverticulosis in a patient with ulcerative colitis
DOI: 10.17235/reed.2020.7529/2020
The use of contrast-enhanced ultrasound for chronic inflammatory bowel disease
DOI: 10.17235/reed.2020.7499/2020
Leukocytoclastic vasculitis with cutaneous and systemic (intestinal) involvement. Diagnosis by capsule endoscopy
DOI: 10.17235/reed.2020.7474/2020
Views of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results
DOI: 10.17235/reed.2020.7472/2020
Capsule retention caused by cryptogenic multifocal ulcerous stenosing enteritis
DOI: 10.17235/reed.2021.7466/2020
Intestinal obstruction secondary to Crohn-like disease in common variable immu-nodeficiency
DOI: 10.17235/reed.2020.7440/2020
Prevalence of pyoderma gangrenosum and Sweet´s syndrome in inflammatory bowel disease at a tertiary healthcare center
DOI: 10.17235/reed.2020.7431/2020
Evaluation of epicardial adipose tissue and carotid intima-media thickness as a marker of atherosclerosis in patients with inflammatory bowel disease
DOI: 10.17235/reed.2020.7394/2020
Autoimmune hepatitis, primary sclerosing cholangitis, and inflammatory bowel disease. Sequential overlap syndrome: a twist to the mosaic of autoimmunity
DOI: 10.17235/reed.2020.7512/2020
Inflammatory bowel disease and solid organ transplantation
DOI: 10.17235/reed.2020.7361/2020
Ustekinumab in Crohn's disease: real-world outcomes and predictors of response
DOI: 10.17235/reed.2020.7352/2020
Can we predict an incomplete capsule endoscopy? Results of a multivariate analysis using a logistic regression model
DOI: 10.17235/reed.2021.7320/2020
Concordance between capsule endoscopy and device-assisted enteroscopy in small-bowel lesions
DOI: 10.17235/reed.2020.7295/2020
Functional gastrointestinal disorders: real-life results of a multidisciplinary non-pharmacological approach based on group-consultations
DOI: 10.17235/reed.2020.7276/2020
Diagnostic yield of the capsule endoscopy and enteroscopy combination for early small bowel carcinoid tumors
DOI: 10.17235/reed.2020.7262/2020
Effectiveness and safety of switching to adalimumab biosimilar ABP 501 in Crohn’s disease: the extrapolation concept
DOI: 10.17235/reed.2020.7253/2020
COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic
DOI: 10.17235/reed.2020.7128/2020
Hepatitis C and beta-thalassemia major in children: experience with glecaprevir/pibrentasvir
DOI: 10.17235/reed.2020.7092/2020
Efficacy, tolerability and safety of a split-dose bowel cleansing regimen of magnesium citrate with sodium picosulfate – a phase IV clinical observational study
DOI: 10.17235/reed.2020.7073/2020
Vitamin D and inflammatory bowel disease: what do we know so far?
DOI: 10.17235/reed.2020.7061/2020
Special Article
Small bowel enteroscopy – A joint clinical guideline by the Spanish and Portuguese small-bowel study groups
DOI: 10.17235/reed.2020.7020/2020
The diagnostic and predictive value of fecal calprotectin and capsule endoscopy for small-bowel Crohn’s disease: a systematic review and meta-analysis
DOI: 10.17235/reed.2020.6996/2020
Intestinal failure in adults and children
DOI: 10.17235/reed.2020.6981/2020
Advanced therapy by device-assisted enteroscopy
DOI: 10.17235/reed.2020.6971/2020
Gastrointestinal and renal involvement in systemic vasculitis
DOI: 10.17235/reed.2020.6965/2020
Obscure gastrointestinal bleeding in the setting of blue rubber bleb nevus syndrome with extensive small bowel involvement
DOI: 10.17235/reed.2020.6963/2020
Does it matter how long the small bowel is?
DOI: 10.17235/reed.2020.6980/2020
Predictors for finding lesions in the small bowel by enteroscopy after a positive capsule endoscopy
DOI: 10.17235/reed.2020.6956/2020
Autoimmune sequential overlap syndrome (autoimmune hepatitis/primary sclerosing cholangitis) and inflammatory bowel disease: three clinical cases
DOI: 10.17235/reed.2020.6938/2020
Gastrointestinal tuberculosis, the great simulator. From inflammatory disease to a tumor
DOI: 10.17235/reed.2020.6934/2020
Waugh’s syndrome: a rare cause of bowel obstruction in adults
DOI: 10.17235/reed.2020.6977/2020
Usefulness of population pharmacokinetics to optimize the dosage regimen of infliximab in inflammatory bowel disease patients
DOI: 10.17235/reed.2020.6857/2020
Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn’s disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain
DOI: 10.17235/reed.2020.6847/2019
The rebleeding rate in patients evaluated for obscure gastrointestinal bleeding after negative small bowel findings by device assisted enteroscopy
DOI: 10.17235/reed.2020.6833/2019
Enteroscopy in the diagnosis of melanoma metastases
DOI: 10.17235/reed.2020.6820/2019
Vedolizumab-associated psoriasis: until where does gut selectivity go?
DOI: 10.17235/reed.2020.6817/2019
A comprehensive systematic review and meta-analysis of risk factors for rebleeding following device-assisted enteroscopy therapy of small-bowel vascular lesions
DOI: 10.17235/reed.2020.6802/2019
A case-control study demonstrates an improved visualization when capsule endoscopy is performed after preparation with polyethylene glycol and ascorbic acid
DOI: 10.17235/reed.2020.6806/2019
Efficacy and safety of water-exchange enteroscopy compared to carbon dioxide insufflation during enteroscopy
DOI: 10.17235/reed.2020.6788/2019
Perforation of the small bowel secondary to capsule endoscopy retention
DOI: 10.17235/reed.2020.6772/2019
An acute episode of inflammatory bowel disease vs a rare manifestation of an Epstein-Barr virus-positive mucocutaneous ulcer. Case report
DOI: 10.17235/reed.2020.6737/2019
Is celiac disease really associated with inflammatory bowel disease?
DOI: 10.17235/reed.2019.6779/2019
Enteroscopic diagnosis of intestinal malabsorption of a rare etiology: diaphragm disease
DOI: 10.17235/reed.2020.6723/2019
The diagnostic value of video capsule endoscopy for Meckel’s diverticulum in children
DOI: 10.17235/reed.2020.6708/2019
Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn’s disease: an observational study
DOI: 10.17235/reed.2020.6693/2019
Association between autoimmune pancreatitis and ulcerative colitis: a report of 12 patients
DOI: 10.17235/reed.2020.6677/2019
Portal venous gas and pneumatosis intestinalis secondary to intestinal subocclusion: success of non-surgical management
DOI: 10.17235/reed.2020.6676/2019
Quality of care through the eyes of the patient in a Spanish inflammatory bowel disease unit
DOI: 10.17235/reed.2020.6620/2019
Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease
DOI: 10.17235/reed.2020.6618/2019
Diet as an environmental trigger in inflammatory bowel disease: a retrospective comparative study in two European cohorts
DOI: 10.17235/reed.2020.6552/2019
A rare association: acute pancreatitis caused by the influenzavirus A with secondary appendicitis in a six-year-old girl
DOI: 10.17235/reed.2020.6532/2019
Rhabdoid cavitated adenocarcinoma in the jejunum, an exceptional case by enteroscopy
DOI: 10.17235/reed.2020.6425/2019
Megacolon in inflammatory bowel disease: response to infliximab
DOI: 10.17235/reed.2020.6394/2019
Detection of polyps in the small bowel of patients with acromegaly via capsule endoscopy
DOI: 10.17235/reed.2020.6377/2019
Status of transition care in inflammatory bowel disease in Spain. Different medical perspectives
DOI: 10.17235/reed.2019.6310/2019
Randomized clinical trial evaluating the effect of a visual educational leaflet on the preparation of colonoscopies in hospitalized patients
DOI: 10.17235/reed.2019.6317/2019
Diet in the etiology of inflammatory bowel disease
DOI: 10.17235/reed.2018.6119/2018
The quality of colonoscopy preparation in a private clinical practice setting
DOI: 10.17235/reed.2019.6074/2018
The main determinants of disability in IBD and its relationship to optimism
DOI: 10.17235/reed.2019.6033/2018
Treat to target in inflammatory bowel disease: a survey of treatment strategies amongst Portuguese doctors
DOI: 10.17235/reed.2019.6029/2018
A rare lymphoproliferative disorder associated with immunomodulating therapy in Crohn’s disease
DOI: 10.17235/reed.2019.5990/2018
Influence of demographic and clinical features of the patient on transit times and impact the on the diagnostic yield of capsule endoscopy
DOI: 10.17235/reed.2019.5971/2018
Small bowel transit time of capsule endoscopy as a factor for the detection of lesions in potential small bowel bleeding
DOI: 10.17235/reed.2019.5943/2018
Consensus document on exclusion diets in irritable bowel syndrome (IBS)
DOI: 10.17235/reed.2018.5941/2018
Case Report
Serrated Lesions in patients with Inflammatory Bowel Disease.
DOI: 10.17235/reed.2019.5910/2018
Preventing incomplete and inadequately cleansed capsule endoscopy examinations. Is it possible?
DOI: 10.17235/reed.2018.5820/2018
The use of serum calprotectin as a biomarker for inflammatory activity in inflammatory bowel disease
DOI: 10.17235/reed.2019.5797/2018
Vitamin D deficiency in outpatients with inflammatory bowel disease: prevalence and association with clinical-biological activity
DOI: 10.17235/reed.2018.5714/2018
Factors that predict the presence of non-small bowel lesions during capsule endoscopy examinations
DOI: 10.17235/reed.2018.5666/2018
Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease
DOI: 10.17235/reed.2019.5600/2018
A pneumoperitoneum due to intestinal cystic pneumatosis associated with a tyrosine kinase inhibitor
DOI: 10.17235/reed.2018.5588/2018
Intramural esophageal dissection. A rare occurrence in pediatric eosinophilic esophagitis
DOI: 10.17235/reed.2018.5577/2018
The association between de novo inflammatory bowel disease and celiac disease
DOI: 10.17235/reed.2019.5535/2018
Perceptions of the public healthcare system from private-care patients with irritable bowel syndrome with constipation in Spain
DOI: 10.17235/reed.2018.5526/2018
Online social networks and inflammatory bowel disease
DOI: 10.17235/reed.2018.5496/2018
A meta-analysis of dietary carbohydrate intake and inflammatory bowel disease risk: evidence from 15 epidemiology studies
DOI: 10.17235/reed.2018.5490/2018
Letter to the Editor
Update of the SEPD position statement on the use of biosimilars for inflammatory bowel disease
DOI: 10.17235/reed.2018.5456/2018
Bowel obstruction secondary to deep infiltrating endometriosis of the ileum
DOI: 10.17235/reed.2018.5364/2017
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months
DOI: 10.17235/reed.2018.5368/2017
Managing iron deficiency and iron deficiency anemia in inflammatory bowel disease. The results of the “Gestiona hierro-EII” survey
DOI: 10.17235/reed.2018.5354/2017
Ectopic pancreas: a very unusual intestinal mass
DOI: 10.17235/reed.2017.5353/2017
Intestinal pneumatosis and pneumoperitoneum in an oncological scenario: a change of attitude
DOI: 10.17235/reed.2017.5333/2017
Long-term results of linaclotide in the treatment of constipation-type irritable bowel syndrome
DOI: 10.17235/reed.2018.5268/2017
Idiopathic portal hypertension with regard to thiopurine treatment
DOI: 10.17235/reed.2018.5256/2017
Duodenal lengthening in an adult with ultra-short bowel syndrome. A case report
DOI: 10.17235/reed.2017.5187/2017
Nutritional deficiency during colonoscopy preparation: the forgotten iatrogeny
DOI: 10.17235/reed.2018.5140/2017
Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index
DOI: 10.17235/reed.2017.5137/2017
Can we rely on inflammatory biomarkers for the diagnosis and monitoring Crohn’s disease activity?
DOI: 10.17235/reed.2017.5126/2017
The complexity of evaluating and increasing adherence in inflammatory bowel disease
DOI: 10.17235/reed.2017.5143/2017
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective
DOI: 10.17235/reed.2017.5078/2017
Capsule endoscopy with PillCamSB2 versus PillCamSB3: has the improvement in technology resulted in a step forward?
DOI: 10.17235/reed.2017.5071/2017
Serrated polyposis syndrome associated with long-standing inflammatory bowel disease
DOI: 10.17235/reed.2017.5068/2017
Spontaneous intramural intestinal hemorrhage due to anticoagulation therapy
DOI: 10.17235/reed.2017.5019/2017
Efficacy of a point-of-care test based on deamidated gliadin peptides for the detection of celiac disease in pediatric patients
DOI: 10.17235/reed.2017.5028/2017
Fecal transplantation as a treatment for Clostridium difficile infection in patients with ulcerative colitis
DOI: 10.17235/reed.2017.4941/2017
High short-term rebleeding rate in patients undergoing a second endoscopic therapy for small-bowel angioectasias after recurrent bleeding
DOI: 10.17235/reed.2017.4872/2017
Continuous esomeprazole infusion versus bolus administration and second look endoscopy for the prevention of rebleeding in children with a peptic ulcer
DOI: 10.17235/reed.2018.4864/2017
Prevalence, risk factors and response to treatment of extra-intestinal manifestations in patients with inflammatory bowel disease
DOI: 10.17235/reed.2017.4845/2017
Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease
DOI: 10.17235/reed.2017.4819/2016
Epidemiology of inflammatory bowel disease in Málaga: incidence rate and follow-up of a cohort diagnosed between 2007-2008
DOI: 10.17235/reed.2017.4708/2016
Symptomatic retention of the Agile® patency capsule
DOI: 10.17235/reed.2017.4691/2016
New psychological therapies for irritable bowel syndrome: mindfulness, acceptance and commitment therapy (ACT)
DOI: 10.17235/reed.2017.4660/2016
Specialist care in the management of inflammatory bowel disease
DOI: 10.17235/reed.2016.4628/2016
Colonic lesions in patients undergoing small bowel capsule endoscopy: incidence, diagnostic and therapeutic impact
DOI: 10.17235/reed.2017.4604/2016
Invasive pulmonary aspergillosis in an immunocompromised patient with severe ulcerative colitis
DOI: 10.17235/reed.2017.4564/2016
Health-related quality of life in adults with irritable bowel syndrome in a Mexican specialist hospital. A cross-sectional study
DOI: 10.17235/reed.2017.4545/2016
The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis
DOI: 10.17235/reed.2016.4470/2016
Previous exposure to biologics and C-reactive protein are associated with the response to tacrolimus in inflammatory bowel disease
DOI: 10.17235/reed.2016.4447/2016
Risk factors for tuberculosis in inflammatory bowel disease: anti-tumor necrosis factor and hospitalization
DOI: 10.17235/reed.2016.4440/2016
How is inflammatory bowel disease managed in Spanish gastroenterology departments? The results of the GESTIONA-EII survey
DOI: 10.17235/reed.2016.4410/2016
Clinical Practice Guideline: Irritable bowel syndrome with constipation and functional constipation in the adult
DOI: 10.17235/reed.2016.4389/2016
Validation of the computed assessment of cleansing score with the Mirocam® system
DOI: 10.17235/reed.2016.4366/2016
Whipple’s disease under the vision of capsule endoscopy
DOI: 10.17235/reed.2016.4362/2016
Asymptomatic bronchial aspiration of capsule endoscope: a significant complication
DOI: 10.17235/reed.2016.4363/2016
Gallstone ileus presenting as obstructive gangrenous appendicitis
Management of the clinical issue of constipation with abdominal complaints in adults. A national survey of Primary Care physicians and gastroenterologists
DOI: 10.17235/reed.2016.4352/2016
Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn’s disease
DOI: 10.17235/reed.2016.4318/2016
Intestinal endometriosis. Our experience
DOI: 10.17235/reed.2016.4292/2016
Jejunal metastasis of renal cell carcinoma
Irritable bowel syndrome (IBS) subtypes: Nothing resembles less an IBS than another IBS
DOI: 10.17235/reed.2016.4195/2016
Pharmaceutical costs for inflammatory bowel disease units — An issue for department heads? The GESTIONAEII survey
DOI: 10.17235/reed.2016.4192/2016
An unusual etiology of abdominal pain in children
DOI: 10.17235/reed.2016.4168/2015
Irritable bowel syndrome subtypes: Clinical and psychological features, body mass index and comorbidities
DOI: 10.17235/reed.2015.3979/2015
Predictive factors of small bowel patency in Crohn's disease patients
DOI: 10.17235/reed.2015.3957/2015
Idiopathic portal hypertension regarding thiopurine treatment in patients with inflammatory bowel disease
DOI: 10.17235/reed.2015.3954/2015
Metastatic Crohn’s disease in pediatrics
DOI: 10.17235/reed.2016.3948/2015
Contribution of infliximab population pharmacokinetic model for dose optimization in ulcerative colitis patients
DOI: 10.17235/reed.2015.3978/2015
Guideline for wireless capsule endoscopy in children and adolescents: A consensus document by the SEGHNP (Spanish Society for Pediatric Gastroenterology, Hepatology, and Nutrition) and the SEPD (Spanish Society for Digestive Diseases)
DOI: 10.17235/reed.2015.3921/2015
Immmunodeficiencies and autoimmune diseases: common variable immunodeficiency and Crohn-like
DOI: 10.17235/reed.2015.3872/2015
Small bowel obstruction due to laparoscopic barbed sutures: An unknown complication?
DOI: 10.17235/reed.2015.3863/2015
Massive gastrointestinal pneumatosis in a patient with celiac disease and superior mesenteric artery syndrome
DOI: 10.17235/reed.2015.3858/2015
Incidence, clinical outcomes, and therapeutic approaches of capsule endoscopy-related adverse events in a large study population
DOI: 10.17235/reed.2015.3820/2015
Rectosigmoid carcinoma presenting with a large small bowel fistula
Management of refractory esophageal stenosis in the pediatric age
DOI: 10.17235/reed.2016.3671/2015
Image of acute bowel ischemia secondary to internal pelvic hernia
Download the citation for this article by clicking on one of the following citation managers:
Received: 30/11/2021
Accepted: 01/12/2021
Online First: 03/12/2021
Published: 07/04/2022
Article Online First time: 3 days
Article editing time: 128 days
Submission and tracking
Access to the information published on the website (www.reed.es) of the Sociedad Española de Patología Digestiva (SEPD), Calle Sancho Dávila, 6, 28028 Madrid, CIF: G28486280, telephone: 914021353, e-mail: sepd@sepd.es, implies acceptance of the following conditions of use:
1. The SEPD published its website in order to make it easier for potential visitors to access information related to its services. The information displayed on this website is made available to users accessing the website, both privately and individually, at no additional cost. The commercialization of access rights is expressly prohibited.
2. It is expressly forbidden to copy or reproduce the information published by means of any electronic medium (web pages, databases, web pages or electronic publications) that allows the dissemination of any information published on this website to multiple users without the prior written consent of the SEPD.
3. Accuracy of information: The SEPD endeavors to display accurate and up-to-date information on its website. However, the SEPD is not responsible for the consequences of reading this information.
4. SEPD is not liable for any damages that the user may cause in connection with access to this website or the use of its contents.
5. Notice to users and/or patients: The information included in www.reed.es is for the exclusive use of healthcare professionals and this will be stated in the registration and access alert.
6. Funding: REED, the official scientific body of the EDPS, shares the same sources of funding as the EDPS, as laid down in Article 22, SECTION VII (ECONOMIC AND DOCUMENTARY SYSTEM) of the EDPS's Statutes.
The website http://www.reed.es may host advertising from third parties that may be considered of interest to the user and in no way a source of budgetary funding for the website. Wherever the word 'Advertising' is displayed, it will be highlighted.
However, advertising that infringes Law 29/2006 on guarantees and rational use of medicines and health products will not be accepted. Likewise, there will be no advertising of any kind in those areas of the website where there may be a conflict of interest.
Advertisers have no rights over their editorial content.
7. Access to restricted areas: In relation to access to restricted areas where the user voluntarily completes the registration form, the EDPS will assign the user a password which will be sent to the e-mail address provided by the user, who must make diligent use of the password and keep it secret. Consequently, the user accepts that he/she is responsible for the correct custody and confidentiality of the password/identifier provided by the EDPS. Furthermore, the user shall not provide access to third parties, either temporarily or permanently, or allow access to third parties.
Consequently, the user is solely responsible for all accesses, contents and actions he/she carries out in connection with his/her user ID and access code, with full indemnity for the EDPS.
On this basis, the user is responsible for immediately informing the EDPS of any factors that allow the misuse of the IDs and/or passwords, such as theft, loss or unauthorized access, in order to cancel them immediately. Until such incidents are reported, SEPD will not be liable for any liability that may arise from the misuse of identifiers or passwords by unauthorized third parties.
The user understands and accepts that he/she is accessing a website with content intended exclusively for medical staff and acknowledges that he/she is a healthcare professional.
Notes of interest to members and visitors to the EDPS website: The data and information contained in all content on these websites are only guidance documents for members and are therefore not legally binding.
8. License for public use of the website: is governed by Spanish law, regardless of the country in which the user accesses the website. Any controversy that may arise in the interpretation of these rules of access will be resolved before the Spanish Courts and Tribunals.
Copyright and Creative Commons POR NC ND: The total or partial reproduction of texts and graphics by any means is prohibited without the express written authorization of the EDPS. To insert these texts, images or news items in the publication or dissemination in any medium of any kind accessible to third parties, the express written consent of the EDPS must be obtained.
The private use of the texts, news and data published on this website is strictly for personal purposes.
The General Data Protection Regulation (Regulation (EU) 2016/679) harmonizes Data Protection legislation across the European Union, increasing the protection of individuals and giving them greater control over their personal data.
At the Spanish Society of Digestive Pathology (SEPD), we have always been concerned about the protection of personal data. We have therefore updated our Privacy Policy in order to bring it into line with the new regulations and to inform you of the changes that affect your rights:
Responsible for the processing of your personal data: SOCIEDAD ESPAÑOLA DE PATOLOGÍA DIGESTIVA (SEPD), CIF: G28486280 and registered office at Calle Sancho Dávila 6, 28028 Madrid.
The data collected by the Sociedad Española de Patología Digestiva (SEPD) are obtained in different ways (website, e-mail, electronic forms or on paper) through its activity as a business association and service provider; these data will become part of an information file for which it is responsible.
Purpose of data collection:
Legitimacy of the processing:
Recipients of the data.
Data subjects:
Everyone can know whether or not the EDPS processes their personal data. They have the right to:
SEPD will cease to process the data, except for legitimate reasons, or for the exercise or defense of possible claims.
Origin of the data: SEPD will obtain personal data directly from the data subject through the following communication channels:
Categories of data:
Sending of commercial communications: In accordance with the LSSI, Law 34/2002, and Law 29/2009, of 30 December, if you do not wish to receive any more commercial communications, please send an e-mail with the word BAJA (unsubscribe) to the following address: sepd@sepd.es.
Security measures: SEPD informs that it has adopted all necessary security measures to prevent theft, alteration or unauthorized access to data, taking into account the state of the art, the costs of implementation, the nature, scope, context and purpose of the processing, as well as the variable risks of probability and severity to the rights and freedoms of individuals, such as in cases of outsourced services, request and ensure that the controller implements appropriate technical and organizational measures to ensure an adequate level of security against existing threats, as stated in art. 32 of the Data Protection Regulation.
Exercise of rights:
Everyone has the right to know whether the EDPS processes his or her personal data. He or she also has the right to:
Access their personal data,
Request the rectification of inaccurate data.
Request deletion when, among other reasons, the data are no longer necessary for the purposes for which they were collected.
Object to the processing of your data, on grounds relating to your particular situation, by requesting that they not be processed by the EDPS.
In certain circumstances, request the restriction of the processing of your data, in which case they will only be kept for the exercise or defense of claims.
Withdraw, at any time, the consent given, without this affecting the lawfulness of the processing that we have carried out prior to such withdrawal.
The interested party may exercise their rights at the following address: Sociedad Española de Patología Digestiva (SEPD), c/ Calle Sancho Dávila, 6 28028 Madrid, or by email to the following address: sepd@sepd.es, any controversy that may arise in the interpretation of these access rules will be resolved before the Spanish Courts and Tribunals.
Remember that whenever you exercise any of the rights set out above, you must accompany your request with a copy of your ID card or equivalent document that allows us to verify your identity.
Likewise, if you are not satisfied with how we have dealt with your rights, you may file a complaint with the Spanish Data Protection Agency, through the website www.aepd.es.
The following table describes in detail the cookies present on the website
The user has also been informed of the cookies used by this website by means of the banner that appears on the home screen during the first browsing visit to this website, in which the user can configure them at their own discretion, requesting their consent and management.
A cookie is a small piece of information, usually a few kilobytes to several megabytes in size, which is stored on your terminal when you visit our website. The cookie is used to remember your preferences and other information about your browsing history of our website.
Cookies can be first-party or third-party cookies. This varies depending on whether the cookies are sent to your terminal from a computer or domain managed by us (own cookies), or are sent from a computer or domain not managed by us (third party cookies). They can remain active from a few minutes to several years, or only during the session.
Cookies can have many purposes and sometimes several are grouped together. In addition, there is a group of technical cookies that are necessary for the proper functioning of website, being mandatory to obtain consent for the rest of the cookies with different purposes. Depending on their purpose we can distinguish,
If you wish, you can also manage cookies through your browser. Most browsers are set by default to accept cookies, but you can change the settings to block, delete and manage some or all cookies if you prefer. Please be aware of the possible changes that can occur when deleting or blocking cookies.
Chrome:
https://support.google.com/chrome/answer/95647?hl=es
Explorer:
https://support.microsoft.com/es-es/topic/eliminar-y-administrar-cookies-168dab11-0753-043d-7c16-ede5947fc64d
Edge:
https://support.microsoft.com/es-es/microsoft-edge/eliminar-las-cookies-en-microsoft-edge-63947406-40ac-c3b8-57b9-2a946a29ae09
Safari:
- Ipad, Iphone, Ipod Touch: https://support.apple.com/es-es/HT201265
- Mac: Preferencias, Panel de privacidad
Firefox:
https://support.mozilla.org/es/kb/Borrar%20cookies